歡迎光臨源葉生物,登錄 | 注冊 |
當前位置: 首頁 > 小分子抑制劑 > Proteases/Proteasome > Bivalirudin

瀏覽歷史

S80250

Bivalirudin

源葉(MedMol) 98%
  • 英文名:
  • Bivalirudin
  • 別名:
  • 比伐盧定;比瓦爾丁;比伐蘆定;三氟醋酸比伐盧定, 三氟醋酸比伐蘆定;三氟醋酸比伐盧定;DPHE-PRO-ARG-PRO-GLY-GLY-GLY-GLY-ASN-GLY-ASP-PHE-GLU-GLU-LLE-PRO-GLU-GLU-TYR-LEU;比伐盧定(醋酸鹽);三氟醋酸比伐蘆定 BIVALIRUDINTRIFLUOROACETATE;BIVALIRUDIN;BIVALIRUDIN TRIFL
  • CAS號:
  • 128270-60-0
  • 分子式:
  • C98H138N24O33
  • 分子量:
  • 2180.29
品牌貨號產(chǎn)品規(guī)格價格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計量單位 加入購物車...
源葉(MedMol) S80250-100mg 98% ¥1100.00元 9 - - - EA 加入購物車
源葉(MedMol) S80250-250mg 98% ¥1500.00元 1 - - - EA 加入購物車
源葉(MedMol) S80250-1g 98% ¥4000.00元 1 - - - EA 加入購物車
大包裝詢價

提交您的電話號碼并同意《個人信息授權與保護申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(1篇)

質檢證書(COA)

摩爾濃度計算器

相關產(chǎn)品

  • 產(chǎn)品描述: Bivalirudin is a reversible inhibitor of α- and ζ-thrombin (Kis = 2.56 and 1.84 nM, respectively), enzymes that exhibit high fibrinogen-clotting activities.
  • 靶點: Thrombin
  • 體內(nèi)研究:
    Deposition in aspirin-treated groups receiving low-, medium-, and high-dose Bivalirudin decreased in a dose-dependent manner by 37%, 44%, and 56%, respectively. As the dose of Bivalirudin was increased, the plasma Bivalirudin levels and activated partial thromboplastin time ratios (final: initial) also increased in a dose-dependent manner. The mean plasma Bivalirudin levels ranged from 0.74 micrograms/ml in the low-dose Bivalirudin group to 2.55 micrograms/ml in the high-dose Bivalirudin group, and the corresponding activated partial thromboplastin time ratios were 1.5 and 3.3
  • 動物實驗: Animals were randomly assigned to one of five groups: control (no aspirin or hirulog); aspirin alone (10 mg/kg); aspirin plus low-dose hirulog (0.2 mg/kg bolus followed by 0.5 mg/kg/hr); aspirin plus medium-dose hirulog (0.4 mg/kg bolus followed by 1.0 mg/kg/hr); or aspirin plus high-dose hirulog (0.6 mg/kg bolus followed by 1.5 mg/kg/hr). Hirulog was infused before surgery and continued until termination of the experiment 30 minutes after endarterectomy
  • 參考文獻:
    1.Hamelink JK, et al. Inhibition of platelet deposition by combined hirulog and aspirin in a rat carotid endarterectomy model. J Vasc Surg. 1995 Mar;21(3):492-8. 2.Witting JI, et al. Thrombin-specific inhibition by and slow cleavage of hirulog-1. Biochem J. 1992 May 1;283 ( Pt 3):737-43. 3.Ofosu FA, et al. Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of alpha-thrombin. Biochem J. 1992 May 1;283 ( Pt 3):893-7.
  • 溶解性: DMSO:10  mM
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 0.459 ml 2.293 ml 4.587 ml
    5 mM 0.092 ml 0.459 ml 0.917 ml
    10 mM 0.046 ml 0.229 ml 0.459 ml
    50 mM 0.009 ml 0.046 ml 0.092 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。
  • 1. 鐘苗, 雷艷, 譚赫,等. 水提取法和仿生提取法研究菲牛蛭不同炮制品的體外抗凝活性[J]. 中國現(xiàn)代中藥, 2020, v.22(03):75-79+93.
輸入產(chǎn)品批號:

本計算器可幫助您計算出特定溶液中溶質的質量、溶液濃度和體積之間的關系,公式為:


質量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。